J&J Defends Win In Second Ovarian Cancer Bellwether Trial In Los Angeles
LOS ANGELES — Johnson & Johnson (J&J) and an affiliate told the California judge who oversaw the second bellwether asbestos-talc ovarian cancer trial that the jury heard sufficient evidence about the...To view the full article, register now.
Already a subscriber? Click here to view full article